Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 731

1.

Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.

Rorstad O.

J Surg Oncol. 2005 Mar 1;89(3):151-60. Review.

PMID:
15719376
2.

Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.

Nikou GC, Lygidakis NJ, Toubanakis C, Pavlatos S, Tseleni-Balafouta S, Giannatou E, Mallas E, Safioleas M.

Hepatogastroenterology. 2005 May-Jun;52(63):731-41.

PMID:
15966194
3.

Biochemical diagnosis of neuroendocrine GEP tumor.

Oberg K.

Yale J Biol Med. 1997 Sep-Dec;70(5-6):501-8. Review.

4.

Carcinoid tumour of the gastrointestinal tract: prognostic factors and disease outcome.

Agranovich AL, Anderson GH, Manji M, Acker BD, Macdonald WC, Threlfall WJ.

J Surg Oncol. 1991 May;47(1):45-52.

PMID:
1708841
5.

Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.

Korse CM, Bonfrer JM, Aaronson NK, Hart AA, Taal BG.

Neuroendocrinology. 2009;89(3):296-301. doi: 10.1159/000162876. Epub 2008 Oct 7.

PMID:
18840995
6.
7.

Gastrointestinal carcinoid tumors.

Eller R, Frazee R, Roberts J.

Am Surg. 1991 Jul;57(7):434-7.

PMID:
2058850
8.

Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors.

Al-Khafaji B, Noffsinger AE, Miller MA, DeVoe G, Stemmermann GN, Fenoglio-Preiser C.

Hum Pathol. 1998 Sep;29(9):992-9.

PMID:
9744317
9.

Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).

de Herder WW.

Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):705-15. Review.

PMID:
16253895
10.

The significance of CD44 expression in gastrointestinal neuroendocrine tumors.

Lai CH, Shan YS, Sy ED, Hsieh YH, Tsai HW, Lee JC, Lin PW.

Hepatogastroenterology. 2005 Jul-Aug;52(64):1071-6.

PMID:
16001632
12.

Classification of low-grade neuroendocrine tumors of midgut and unknown origin.

Van Eeden S, Quaedvlieg PF, Taal BG, Offerhaus GJ, Lamers CB, Van Velthuysen ML.

Hum Pathol. 2002 Nov;33(11):1126-32.

PMID:
12454818
13.

[Surgical therapy of carcinoid tumors of the gastrointestinal tract].

Böttger T.

Zentralbl Chir. 2001 Sep;126(9):676-81. German.

PMID:
11699282
14.

Proposed staging system for gastrointestinal carcinoid tumors.

Landry CS, McMasters KM, Scoggins CR, Martin RC 2nd.

Am Surg. 2008 May;74(5):418-22.

PMID:
18481499
15.

Neuroendocrine tumours: clinical presentation and management of localized disease.

Kulke MH.

Cancer Treat Rev. 2003 Oct;29(5):363-70. Review.

PMID:
12972355
16.

Bronchopulmonary carcinoid tumors--a significant diagnostic problem.

Kedra P, Jeleń M, Szkudlarek-Gruszczyńska T, Leśkow E.

Rocz Akad Med Bialymst. 1997;42 Suppl 1:146-61. Review.

PMID:
9337533
17.

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.

Panzuto F, Nasoni S, Falconi M, Corleto VD, Capurso G, Cassetta S, Di Fonzo M, Tornatore V, Milione M, Angeletti S, Cattaruzza MS, Ziparo V, Bordi C, Pederzoli P, Delle Fave G.

Endocr Relat Cancer. 2005 Dec;12(4):1083-92.

18.

Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors.

Safatle-Ribeiro AV, Ribeiro U Jr, Corbett CE, Iriya K, Kobata CH, Sakai P, Yagi OK, Pinto PE Jr, Zilberstein B, Gama-Rodrigues J.

Eur J Gastroenterol Hepatol. 2007 Jan;19(1):21-8.

PMID:
17206073
19.

Gastrointestinal carcinoid tumors: current management strategies.

Memon MA, Nelson H.

Dis Colon Rectum. 1997 Sep;40(9):1101-18. Review.

PMID:
9293943
20.

Carcinoid tumors and syndrome.

Feldman JM.

Semin Oncol. 1987 Sep;14(3):237-46. No abstract available.

PMID:
2442815

Supplemental Content

Support Center